3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Depression
2
Breast Neoplasms
2
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Inflammatory Breast Neoplasms
1
Constriction, Pathologic
1
Carcinoma, Basal Cell
1
Anxiety Disorders
1
Interventions
X-Rays
7
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Biopsy
7
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Temozolomide
5
Cyclophosphamide
5
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
fludarabine phosphate
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Topotecan
2
Etoposide
2
Doxorubicin
2
Carboplatin
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Therapeutics
×
30 days
×
Clear all
No trials found.